EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS118-08417 
Organism
Homo sapiens 
Tissue/cell
Liver 
Coordinate
chr17:76711140-76713010 
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
GLI2MA0734.2chr17:76711275-76711290AGACCACCCACGAGG+7.15
Number of super-enhancer constituents: 33             
IDCoordinateTissue/cell
SE_03593chr17:76711023-76712412Brain_Angular_Gyrus
SE_03593chr17:76712585-76716199Brain_Angular_Gyrus
SE_04177chr17:76710362-76716568Brain_Anterior_Caudate
SE_05030chr17:76709033-76722335Brain_Cingulate_Gyrus
SE_06197chr17:76709480-76716750Brain_Hippocampus_Middle
SE_07013chr17:76709128-76722223Brain_Hippocampus_Middle_150
SE_08280chr17:76709155-76716729Brain_Inferior_Temporal_Lobe
SE_09291chr17:76711164-76712866CD14
SE_10232chr17:76710234-76716463CD19_Primary
SE_10917chr17:76699585-76716888CD20
SE_14447chr17:76710268-76711913CD4_Memory_Primary_7pool
SE_16882chr17:76711114-76712183CD4p_CD225int_CD127p_Tmem
SE_17330chr17:76710288-76716652CD4p_CD25-_CD45RAp_Naive
SE_17789chr17:76710408-76716366CD4p_CD25-_CD45ROp_Memory
SE_18275chr17:76708858-76756450CD4p_CD25-_Il17-_PMAstim_Th
SE_19133chr17:76710328-76716614CD4p_CD25-_Il17p_PMAstim_Th17
SE_20047chr17:76710271-76713495CD56
SE_22344chr17:76709216-76716514CD8_primiary
SE_26201chr17:76711511-76713321Duodenum_Smooth_Muscle
SE_32461chr17:76709187-76716237GM12878
SE_39457chr17:76710273-76715896Jurkat
SE_43543chr17:76711343-76716562MM1S
SE_49999chr17:76711125-76716429RPMI-8402
SE_50271chr17:76712792-76715583Sigmoid_Colon
SE_52658chr17:76712722-76715493Small_Intestine
SE_53636chr17:76711249-76712312Spleen
SE_59073chr17:76687338-76733905Ly3
SE_60415chr17:76679151-76756346DHL6
SE_60995chr17:76690240-76779668HBL1
SE_61668chr17:76693174-76787177Toledo
SE_62236chr17:76690401-76817069Tonsil
SE_66337chr17:76710273-76715896Jurkat
SE_67253chr17:76711343-76716562MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr177671128376712268
Enhancer Sequence
TAAGCAAAAA AATAAACTCG GTTGAATAAA AATATTTTTA AATCCCACAG AGAAATTCTC 60
ATAGGAAAAA TTCAGAAGTT CCAGGAATAA AGACGATCCT AAAACCTCCA CAGAGGTTAA 120
GGAGAGTGAT TAATCAGACC ACCCACGAGG GAAGATCTCG CTGGTGTCAG TATAAGAGCC 180
CGCACACTAA AGATAGCGCA GTGGAACTTT CAAAATTCTA AATGAAAATT ATCTGAACCC 240
CAAATTCTCA GTCAAGTAGG AGGGTAAAAC AGACTCATTT CAGATACATA AGGATCAGAA 300
AGTTTGTCTT CTGTGCACCC CTTCTGAAGA AGCTACTTCA GGAGCAAGAT GTGGATCAAG 360
GAACGGGACT GACTCAGGAG CCTGAGGACA GCAAGCGCCA TCAACTGTGA TGGCCAACAG 420
CCACCAGACC GGGTCAGAGC AGGAAGCCAA AGGGCTGCCA GAGGAATGCC ATCAGAAAGA 480
ATGAAATCAG ACTCGAAACC AGAGAATGAA GGAGAAAGCA GCTGAGAAAA CTGTGTGATA 540
CCAACAGGCA TCATTCGGTT TCCTCTCAAG AGAATAAAAA GGACTGGGCA ACAGGAAAAA 600
CTCAACTACA GGAAATCACA GAAGAAATGA AACATGCCCC CCGAGTGGTG TCCTCTGGGC 660
CATCAGGGAC GCCAGGAACA GCTCCCTTTG AGTGGGCACC TGGCTCTACG GTGAGTGGTA 720
TCTACATTCC TGTCATGGTG CTGGTCGCTG GTAGTTAACT TACAGAATCA CCCTGTAGAC 780
AAAGCATGAA AGACCAACCC AGGCTGGAGA AGCAAAGCTA TCTGTTACCA AGGTGAAGGA 840
AGAGCTGACC AAAGTTTGAG GGAAGCAAAG TGGAGAGGGC AGCAGGGTCC CAAATGGTCC 900
CCACAGCTTC CTCCTACAAC ACTAGAGACC AGAGGCATGG ATAAGGATCA TGAACAAGAA 960
ACCCACGCTG TAAATATGCC AAAGGTAAAA ATCCAGGAAC TGAAAATTGT GATCAACTAC 1020
CAAAAATGGA CAGTGAGAGA AGGAAGGAAG AGAATGGTGT GAGCTGCATC CTCATCCATC 1080
ATAGGCAGAA GGCAGGAGAT AACCTTTGAT CTTGACAAAA TAATCACCAA TTTAAGAACT 1140
TGGCAGCACC CACTAGAAGA CCTAAAAGCA GAAAAAAGTG AATTAATAGT GGCTGCTTTG 1200
GGGAGTGGGT CTGGGAATAG AGAGACAGGA CATATAAGCC CCTGAATACT TGCTTTAAAA 1260
TACATATATA TATGTACTAT GACAATTTGA AAACAAAAGA CTAAAAATGT ACAACTATGG 1320
TCACTAGAAA AGATAGCCCT TCTGTGTCCT TGGAGTCAGA CAGAAAACGC TTCTGGCCAA 1380
TTTGTAGCTA GAATAAATAA GACATTTATC TACATTTATT TTGATCCAAT CTCCTGACAT 1440
TTGCCACATG ACTGCTAAAT TACTTCTCCA TTCCATACTT ACTAACTTTA AATCATAATG 1500
CTGCTCCCCT TCTGGCTCAA CCAATCATTC AAGAACTTTA TTTTAAAAAG CTGAACTACA 1560
CCTCATTTTT CTAGTGGAAT TTTATTCTGA GATGAGGCAA AATCTAATAT TTTAATAAGT 1620
ATTTTCCTCT GCATAAACTT AACAATGCAA CATCAAATCT TTAATTCAAG CCTTCATTCT 1680
CATGCTGCCC CGGACAGAAA AAACATCCAA AAACAAAATG CTTAATTTCA TTTAGCAGCA 1740
TGAAGAATCA ACACTATTGC TGGAGAGCTG AGGTGTGATT GATTCCTACA GTCTTGGCTA 1800
GTGTCTTCAG GACACTGCGA AGGCCACAGC TGGAACAAGA AAGGTGGTGG TCAGAAATAC 1860
CCATGTCTAC 1870